QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scott, H. L. Articles by Dodd, P. R. Search for Related Content PubMed PubMed Citation Articles by Scott, H. L. Articles by Dodd, P. R.

 Previous Article  |  Next Article 

The Journal of Neuroscience, 2002, 22:RC206:1-5

RAPID COMMUNICATION
Aberrant Expression of the Glutamate Transporter Excitatory Amino Acid Transporter 1 (EAAT1) in Alzheimer's Disease

Heather L. Scott¹, David V. Pow², Anthony E. G. Tannenberg³, and Peter R. Dodd¹

Departments of ¹ Biochemistry and ² Physiology and Pharmacology, University of Queensland, Brisbane, Queensland, Australia, 4072, and ³ Pathology Department, Mater Misericordiæ Hospital, South Brisbane, Queensland, Australia, 4101

Glutamate-mediated toxicity has been implicated in the neurodegeneration observed in Alzheimer's disease. In particular, glutamate transport dysfunction may increase susceptibility to glutamate toxicity, thereby contributing to neuronal cell injury and death. In this study, we examined the cellular localization of the glial glutamate transporter excitatory amino acid transporter 1 (EAAT1) in the cerebral cortex of control, Alzheimer's disease, and non-Alzheimer dementia cases. We found that EAAT1 was strongly expressed in a subset of cortical pyramidal neurons in dementia cases showing Alzheimer-type pathology. In addition, tau (which is a marker of neurofibrillary pathology) colocalized to those same pyramidal cells that expressed EAAT1. These findings suggest that EAAT1 changes are related to tau expression (and hence neurofibrillary tangle formation) in dementia cases showing Alzheimer-type pathology. This study implicates aberrant glutamate transporter expression as a mechanism involved in neurodegeneration in Alzheimer's disease.

Key words: Alzheimer's disease; glutamate transporter; EAAT1; tau; immunocytochemistry; human cortex

---

Copyright © Society for Neuroscience  0270-6474//$05.00/0

This article has been cited by other articles:

				D. Torres-Salazar and C. Fahlke Parawixin1: A Spider Toxin Opening New Avenues for Glutamate Transporter Pharmacology Mol. Pharmacol., November 1, 2007; 72(5): 1100 - 1102. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help